Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary
- 4 December 2015
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 27 (4) , 322-327
Abstract
Background: Collecting reliable and valid symptom information from patients is critical for assessing psoriasis severity in clinical research. Objective: To evaluate measurement properties of a new patient-reported outcome (PRO), the Psoriasis Symptoms and Signs Diary (PSSD). Methods: One hundred six US patients with moderate-to-severe plaque psoriasis completed two versions of the PSSD [a 24-hour recall (PSSD-24h) and 7-day recall (PSSD-7d)] using a 0–10 numerical rating scale. Reliability (test-retest and internal consistency), validity (convergent, divergent and known-groups), responsiveness, and version equivalence were evaluated. Minimally important difference was estimated. Results: Based on exploratory factor analysis and clinical input, symptom, sign, and total severity scores were established. Internal consistency (Cronbach’s alpha ≥ 0.944) and test-retest reliability (intraclass correlation coefficients ≥ 0.824) were acceptable. Correlations with Dermatology Life Quality Index (DLQI) (0.489 to 0.644) indicated convergent validity, while low correlations (< 0.30) with several Short Form (SF)-36 scales indicated divergent validity. PSSD scores differed when patients were categorized by Body Surface Area, DLQI, and Psoriasis Area Severity Index scores. PSSD-24h and PSSD-7d versions were equivalent (Pearson correlations ≥ 0.953). Limitations: PSSD responsiveness should be evaluated in patients receiving treatment. Conclusion: The PSSD is reliable and valid in measuring symptoms/signs of patients with moderate-to-severe plaque psoriasis.Keywords
This publication has 21 references indexed in Scilit:
- Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011PLOS ONE, 2012
- Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social LifeActa Dermato-Venereologica, 2012
- Patient-reported outcomes in psoriasis research and practiceBritish Journal of Dermatology, 2011
- Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trialBritish Journal of Dermatology, 2009
- The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsHealth and Quality of Life Outcomes, 2009
- The impact of psoriasis on quality of lifeBritish Journal of Dermatology, 2001
- Evaluating quality-of-life and health status instruments: development of scientific review criteriaClinical Therapeutics, 1996
- Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosisJournal of Clinical Epidemiology, 1995
- The rand 36‐item health survey 1.0Health Economics, 1993
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951